Literature DB >> 10571287

Regulation of paracellular absorption of cimetidine and 5-aminosalicylate in rat intestine.

S Y Zhou1, N Piyapolrungroj, L Pao, C Li, G Liu, E Zimmermann, D Fleisher.   

Abstract

PURPOSE: Isolating the relative contributions of parallel transcellular and paracellular transport to the intestinal absorption of small hydrophilic molecules has proven experimentally challenging. In this report, lumenal appearance of drug metabolite is utilized as a tool to assess the contribution of paracellular transport to the absorption of cimetidine and 5-aminosalicylate (5ASA) in rat small intestine.
METHODS: Steady-state intestinal absorption and elimination of cimetidine and 5ASA were studied in single-pass intestinal perfusions in rats.
RESULTS: Both drugs were metabolized in intestinal epithelia with subsequent metabolite secretion into the intestinal lumen. Jejunal cimetidine absorption decreased with increasing perfusion concentration while the ratio of lumenal metabolite to lumenal drug loss increased. Cimetidine uptake at perfusion concentrations above 0.4 mM resulted in over 80% drug elimination into the jejunal lumen. Inhibition of intracellular metabolism of cimetidine by methimazole did not alter epithelial uptake but totally abolished transepithelial cimetidine flux indicating an elevation of intracellular cimetidine. Similarly, co-perfusion of 5ASA with cimetidine and methimazole totally abolished 5ASA absorption but increased lumenal levels of N-acetyl 5ASA indicating an increase in intracellular uptake of 5ASA.
CONCLUSIONS: Cimetidine and 5ASA absorption across rat jejunal epithelia are exclusively paracellular. Elevation of intracellular cimetidine, inferred from mass balance considerations, restricts paracellular transport of both drugs.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571287     DOI: 10.1023/a:1018974519984

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Cimetidine transport in brush-border membrane vesicles from rat small intestine.

Authors:  N Piyapolrungroj; C Li; R L Pisoni; D Fleisher
Journal:  J Pharmacol Exp Ther       Date:  1999-04       Impact factor: 4.030

2.  Different size limitations for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets.

Authors:  J M Mullin; C W Marano; K V Laughlin; M Nuciglio; B R Stevenson; P Soler
Journal:  J Cell Physiol       Date:  1997-05       Impact factor: 6.384

Review 3.  Routes and mechanism of fluid transport by epithelia.

Authors:  K R Spring
Journal:  Annu Rev Physiol       Date:  1998       Impact factor: 19.318

4.  Estimation of the relative contribution of the transcellular and paracellular pathway to the transport of passively absorbed drugs in the Caco-2 cell culture model.

Authors:  V Pade; S Stavchansky
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

5.  Modulation of intestinal paracellular permeability by intracellular mediators and cytoskeleton.

Authors:  M Pérez; A Barber; F Ponz
Journal:  Can J Physiol Pharmacol       Date:  1997-04       Impact factor: 2.273

6.  Pharmacokinetic drug interactions between triamterene and ranitidine in humans: alterations in renal and hepatic clearances and gastrointestinal absorption.

Authors:  M Muirhead; F Bochner; A Somogyi
Journal:  J Pharmacol Exp Ther       Date:  1988-02       Impact factor: 4.030

7.  Size-dependent permeability of hydrophilic probes across rabbit colonic epithelium.

Authors:  H Ghandehari; P L Smith; H Ellens; P Y Yeh; J Kopecek
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

Review 8.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

9.  Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars.

Authors:  R M van Elburg; J J Uil; F T Kokke; A M Mulder; W G van de Broek; C J Mulder; H S Heymans
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-02       Impact factor: 2.839

10.  Intestinal clearance of H2-antagonists.

Authors:  Y F Hui; J Kolars; Z Hu; D Fleisher
Journal:  Biochem Pharmacol       Date:  1994-07-19       Impact factor: 5.858

View more
  6 in total

Review 1.  The mucosa of the small intestine: how clinically relevant as an organ of drug metabolism?

Authors:  Margaret M Doherty; William N Charman
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Intestinal absorptive transport of the hydrophilic cation ranitidine: a kinetic modeling approach to elucidate the role of uptake and efflux transporters and paracellular vs. transcellular transport in Caco-2 cells.

Authors:  David L Bourdet; Gary M Pollack; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

Review 3.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

4.  Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.

Authors:  David L Bourdet; Dhiren R Thakker
Journal:  Pharm Res       Date:  2006-06-08       Impact factor: 4.200

5.  In vitro transport characteristics of EFdA, a novel nucleoside reverse transcriptase inhibitor using Caco-2 and MDCKII cell monolayers.

Authors:  Wei Zhang; Michael A Parniak; Stefan G Sarafianos; Philip E Empey; Lisa C Rohan
Journal:  Eur J Pharmacol       Date:  2014-03-29       Impact factor: 4.432

6.  Evaluation of potential of Zn-pectinate gel (ZPG) microparticles containing mesalazine for colonic drug delivery.

Authors:  J Kawadkar; K Chauhan Meenakshi; A Ram
Journal:  Daru       Date:  2010       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.